CAPTRUST Financial Advisors
PRAX icon

CAPTRUST Financial Advisors’s Praxis Precision Medicines PRAX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$721K Buy
+2,153
New +$682K ﹤0.01% 1936
2022
Q3 		– Sell
-90
Closed -$3K – 3517
2022
Q2 		$3K Buy
+90
New +$9.61K ﹤0.01% 4328
2022
Q1 		– Sell
-4
Closed -$1K – 5085
2021
Q4 		$1K Hold
4
– – ﹤0.01% 4616
2021
Q3 		$1K Buy
+4
New +$1.08K ﹤0.01% 4470
2021
Q2 		– Sell
-1
Closed – – 4626
2021
Q1 		$0 Buy
+1
New +$711 ﹤0.01% 4446

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

CAPTRUST Financial Advisors's PRAX Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 2,153 shares worth $721K. The stake represents ﹤0.01% of the portfolio and ranks #1936 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in PRAX as recently as Q2 2022.

CAPTRUST Financial Advisors first reported a position in PRAX in Q1 2021 and has held it in 5 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • CAPTRUST Financial Advisors held 2,153 shares of Praxis Precision Medicines worth $721K as of Q2 2026.
  • Praxis Precision Medicines was a new CAPTRUST Financial Advisors position in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1936 holding.
  • CAPTRUST Financial Advisors first reported a position in Praxis Precision Medicines in Q1 2021 and has held it in 5 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.